CONTROLLED CLINICAL-TRIAL OF ADJUVANT IMMUNOTHERAPY WITH BCG AND NEURAMINIDASE-TREATED AUTOLOGOUS TUMOR-CELLS IN LARGE BOWEL-CANCER

被引:31
作者
GRAY, BN
WALKER, C
ANDREWARTHA, L
FREEMAN, S
BENNETT, RC
机构
关键词
D O I
10.1002/jso.2930400109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:34 / 37
页数:4
相关论文
共 20 条
[1]  
AMBUS A, 1978, DEV BIOL STAND, V38, P541
[2]   IMMUNOLOGICAL APPROACH TO CANCER-THERAPY [J].
GRAY, BN ;
WATKINS, E .
MEDICAL CLINICS OF NORTH AMERICA, 1975, 59 (02) :327-337
[3]   MELBOURNE TRIAL OF ADJUVANT IMMUNOTHERAPY IN OPERABLE LARGE BOWEL-CANCER [J].
GRAY, BN ;
WALKER, C ;
ANDREWARTHA, L ;
FREEMAN, S ;
BENNETT, RC .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1988, 58 (01) :43-46
[4]   SURGICAL ADJUVANT THERAPY FOR POTENTIALLY CURABLE CANCER - RATIONALE OF ADJUVANT CHEMOTHERAPY AND ANTICOAGULANT THERAPY [J].
GRAY, BN .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1977, 47 (05) :576-580
[5]  
HIGGINS GA, 1984, CANCER, V54, P193, DOI 10.1002/1097-0142(19840715)54:2<193::AID-CNCR2820540202>3.0.CO
[6]  
2-F
[7]  
HOLLAND J, 1978, IMMUNOTHERAPY CANCER, V6, P347
[8]  
HOOVER HC, 1984, CANCER RES, V44, P1671
[9]  
HOOVER HC, 1985, CANCER, V55, P1236, DOI 10.1002/1097-0142(19850315)55:6<1236::AID-CNCR2820550616>3.0.CO
[10]  
2-#